Personalized sequencing and the future of medicine: discovery, diagnosis and defeat of disease

被引:51
|
作者
Esplin, Edward D. [1 ]
Oei, Ling [1 ]
Snyder, Michael P. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA
关键词
cancer genomics; disease discovery; electronic medical record; genomic medicine; individualized therapy; next-generation sequencing; personalized medicine; pharmacogenetics; pharmacogenomics; precision medicine; prevention; whole-exome sequencing; whole-genome sequencing; REVERSE-TRANSCRIPTASE; ENVIRONMENTAL-FACTORS; CLONAL EVOLUTION; CANCER GENOME; WHOLE-EXOME; MUTATIONS; ASSOCIATION; HYPERSENSITIVITY; HLA-B-ASTERISK-5701; RISK;
D O I
10.2217/pgs.14.117
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The potential for personalized sequencing to individually optimize medical treatment in diseases such as cancer and for pharmacogenomic application is just beginning to be realized, and the utility of sequencing healthy individuals for managing health is also being explored. The data produced requires additional advancements in interpretation of variants of unknown significance to maximize clinical benefit. Nevertheless, personalized sequencing, only recently applied to clinical medicine, has already been broadly applied to the discovery and study of disease. It is poised to enable the earlier and more accurate diagnosis of disease risk and occurrence, guide prevention and individualized intervention as well as facilitate monitoring of healthy and treated patients, and play a role in the prevention and recurrence of future disease. This article documents the advancing capacity of personalized sequencing, reviews its impact on disease-oriented scientific discovery and anticipates its role in the future of medicine.
引用
收藏
页码:1771 / 1790
页数:20
相关论文
共 50 条
  • [1] Precision Medicine and Personalized Medicine in Cardiovascular Disease
    Currie, Gemma
    Delles, Christian
    SEX-SPECIFIC ANALYSIS OF CARDIOVASCULAR FUNCTION, 2018, 1065 : 589 - 605
  • [2] Challenges of drug discovery for personalized medicine
    Jain, Kewal K.
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2006, 8 (06) : 487 - 492
  • [3] Genomic-based diagnosis of arrhythmia disease in a personalized medicine era
    Omar, Abdullah
    Zhou, Mi
    Berman, Adam
    Sorrentino, Robert A.
    Yar, Neela
    Weintraub, Neal L.
    Kim, Il-man
    Lei, Wei
    Tang, Yaoliang
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2016, 1 (06): : 497 - 504
  • [4] The future of drug discovery and development: Shifting emphasis towards personalized medicine
    Amir-Aslani, Arsia
    Mangematin, Vincent
    TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 2010, 77 (02) : 203 - 217
  • [5] Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing
    Adekile, Adekunle
    Akbulut-Jeradi, Nagihan
    Al Khaldi, Rasha
    Fernandez, Maria Jinky
    Sukumaran, Jalaja
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (06):
  • [6] The Limits and Potential Future Applications of Personalized Medicine to Prevent Complex Chronic Disease
    Bergquist, Sharon Horesh
    Lobelo, Felipe
    PUBLIC HEALTH REPORTS, 2018, 133 (05) : 519 - 522
  • [7] Toward knowing the whole human: next-generation sequencing for personalized medicine
    Toma, Ian
    St Laurent, Georges, III
    McCaffrey, Timothy A.
    PERSONALIZED MEDICINE, 2011, 8 (04) : 483 - 491
  • [8] Personalized Medicine in the Care of the Child with Congenital Heart Disease: Discovery to Application
    Marvasti, Tina Binesh
    D'Alessandro, Lisa C. A.
    Manase, Dorin
    Papaz, Tanya
    Mital, Seema
    CONGENITAL HEART DISEASE, 2013, 8 (03) : 266 - 269
  • [9] Personalized medicine in old age psychiatry and Alzheimer's disease
    Siafarikas, Nikias
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [10] The future of personalized medicine in Saudi Arabia Opportunities and challenges
    Mawkili, Wedad A.
    SAUDI MEDICAL JOURNAL, 2025, 46 (01) : 19 - 25